BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18927094)

  • 1. Early reporting for cancer screening trials.
    Baker SG; Kramer BS; Prorok PC
    J Med Screen; 2008; 15(3):122-9. PubMed ID: 18927094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of postscreening follow-up time and participant characteristics on estimates of overdiagnosis from lung cancer screening trials.
    Li M; Zhang L; Charvat H; Callister ME; Sasieni P; Christodoulou E; Kaaks R; Johansson M; Carvalho AL; Vaccarella S; Robbins HA
    Int J Cancer; 2022 Nov; 151(9):1491-1501. PubMed ID: 35809038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality From Postscreening (Interval) Colorectal Cancers Is Comparable to That From Cancer in Unscreened Patients-A Randomized Sigmoidoscopy Trial.
    Jodal HC; Løberg M; Holme Ø; Adami HO; Bretthauer M; Emilsson L; Ransohoff DF; Hoff G; Kalager M
    Gastroenterology; 2018 Dec; 155(6):1787-1794.e3. PubMed ID: 30165051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population impact of lung cancer screening in the United States: Projections from a microsimulation model.
    Criss SD; Sheehan DF; Palazzo L; Kong CY
    PLoS Med; 2018 Feb; 15(2):e1002506. PubMed ID: 29415013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
    Shen Y; Yang Y; Inoue LY; Munsell MF; Miller AB; Berry DA
    J Natl Cancer Inst; 2005 Aug; 97(16):1195-203. PubMed ID: 16106024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
    Mandelblatt JS; Stout NK; Schechter CB; van den Broek JJ; Miglioretti DL; Krapcho M; Trentham-Dietz A; Munoz D; Lee SJ; Berry DA; van Ravesteyn NT; Alagoz O; Kerlikowske K; Tosteson AN; Near AM; Hoeffken A; Chang Y; Heijnsdijk EA; Chisholm G; Huang X; Huang H; Ergun MA; Gangnon R; Sprague BL; Plevritis S; Feuer E; de Koning HJ; Cronin KA
    Ann Intern Med; 2016 Feb; 164(4):215-25. PubMed ID: 26756606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data.
    Swedish Organised Service Screening Evaluation Group
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):45-51. PubMed ID: 16434585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimate of lung cancer mortality from low-dose spiral computed tomography screening trials: implications for current mass screening recommendations.
    Patz EF; Swensen SJ; Herndon JE
    J Clin Oncol; 2004 Jun; 22(11):2202-6. PubMed ID: 15169809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
    Horeweg N; Scholten ET; de Jong PA; van der Aalst CM; Weenink C; Lammers JW; Nackaerts K; Vliegenthart R; ten Haaf K; Yousaf-Khan UA; Heuvelmans MA; Thunnissen E; Oudkerk M; Mali W; de Koning HJ
    Lancet Oncol; 2014 Nov; 15(12):1342-50. PubMed ID: 25282284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Projecting the yearly mortality reductions due to a cancer screening programme.
    Liu ZA; Hanley JA; Strumpf EC
    J Med Screen; 2013; 20(3):157-64. PubMed ID: 24045921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for lung cancer: A systematic review and meta-analysis.
    Usman Ali M; Miller J; Peirson L; Fitzpatrick-Lewis D; Kenny M; Sherifali D; Raina P
    Prev Med; 2016 Aug; 89():301-314. PubMed ID: 27130532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
    Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
    Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Czech Study on Lung Cancer Screening: post-trial follow-up of lung cancer deaths up to year 15 since enrollment.
    Kubík AK; Parkin DM; Zatloukal P
    Cancer; 2000 Dec; 89(11 Suppl):2363-8. PubMed ID: 11147613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tuberculosis in Iceland. 1976].
    Sigurdsson S
    Laeknabladid; 2005 Jan; 91(1):69-102. PubMed ID: 16155306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the biomarker pipeline to develop and evaluate cancer screening tests.
    Baker SG
    J Natl Cancer Inst; 2009 Aug; 101(16):1116-9. PubMed ID: 19574417
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.